Section 5: Patient Safety and Quality Assurance

5PSQ-017

IMPLEMENTATION AND MONITORING OF A PROTOCOL FOR THE USE OF INTRAVENOUS IRON

5PSQ-016

UNFAVOURABLE OUTCOMES OF BLOOD TRANSFUSIONS IN HOSPITALISED ANAEMIC PATIENTS

5PSQ-015

DRUG INTERACTION BETWEEN NOACs AND ITRACONAZOLE: AN ITALIAN DISTRICT ANALYSIS

5PSQ-014

NOVEL ORAL ANTICOAGULANTS VS VITAMIN K ANTAGONISTS: A COST ANALYSIS

5PSQ-013

PRESCRIPTIONS OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS ADMITTED

5PSQ-012

IMPACT OF THERAPEUTIC PATIENT EDUCATION IN THE PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH CANCER

5PSQ-011

VENOUS THROMBOEMBOLIC EVENTS AND TOTAL HIP OR KNEE ARTHROPLASTY: INCIDENCE AND ASSOCIATED FACTORS

5PSQ-010

MANIPULATION OF WARFARIN TABLETS IN PAEDIATRIC CARE: DO WE GIVE THE RIGHT DOSE?

5PSQ-009

CYP2C19 SNP´S INFLUENCE ON CLOPIDOGREL RESPONSE IN CEREBROVASCULAR DISEASE PATIENTS: FINAL RESULTS

5PSQ-008

CYP2C19 SNP´S INFLUENCE ON CLOPIDOGREL RESPONSE IN PERIPHERAL ARTERY DISEASE PATIENTS

5PSQ-007

SEBELIPASE ALFA AS ENZYME REPLACEMENT THERAPY IN THREE PAEDRIATRIC PATIENTS

5PSQ-006

USE OF SUBSTITUTE ENZYMATIC TREATMENT AND SUBSTRATE REDUCTION IN GAUCHER DISEASE

5PSQ-005

SAFETY AND EFFICACY OF FAST-ACTING INSULIN ADDED TO TOTAL PARENTERAL NUTRITION

5PSQ-004

OBSERVATIONAL STUDY OF THE EVOLUTION OF BLOOD GLUCOSE LEVELS AFTER THE CHANGE TO INSULIN DEGLUDEC

5PSQ-003

A QUALITATIVE ANALYSIS OF BARRIERS TO MEDICATION ADHERENCE IN UNCONTROLLED DIABETES – FOCUS ON INSULIN AND SUGGESTIONS FOR PRACTICE IMPROVEMENTS

Pages